code,description,last_updated
100000-9,Health informatics pioneer and the father of LOINC,09-06-2025
100001-7,Health informatics pioneer and cofounder of LOINC,09-06-2025
100002-5,Specimen care is maintained,09-06-2025
100003-3,Team communication is maintained throughout care,09-06-2025
100004-1,Demonstrates knowledge of the expected psychosocial responses to the procedure,09-06-2025
100005-8,Demonstrates knowledge of nutritional management related to the procedure,09-06-2025
100006-6,Demonstrates knowledge of medication management,09-06-2025
100007-4,Demonstrates knowledge of pain management,09-06-2025
10000-8,R wave duration in lead AVR,09-06-2025
100008-2,Demonstrates knowledge of wound management,09-06-2025
100009-0,Demonstrates knowledge of the procedure and expected results,09-06-2025
100010-8,"No injury related to procedure equipment, medical supplies, or instrumentation",09-06-2025
100011-6,No injury related to an electrical source,09-06-2025
100012-4,Participates in decisions affecting the patient's plan of care,09-06-2025
100013-2,Participates in the discharge process,09-06-2025
100014-0,Psychosocial health is maintained at or improved from baseline,09-06-2025
100015-7,No injury related to positioning due to care or procedure,09-06-2025
10001-6,R wave duration in lead I,09-06-2025
100016-5,No injury related to a laser source,09-06-2025
100017-3,Perioperative nursing data set outcomes panel [PNDS],09-06-2025
100018-1,Hospice care Note,09-06-2025
100019-9,ALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,09-06-2025
100020-7,GNA11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,09-06-2025
100021-5,GNAQ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,09-06-2025
100022-3,IDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,09-06-2025
100023-1,IDH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,09-06-2025
10002-4,R wave duration in lead II,09-06-2025
100024-9,SETBP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,09-06-2025
100025-6,SRSF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,09-06-2025
100026-4,MET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,09-06-2025
100027-2,SMAD4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,09-06-2025
100028-0,FBXW7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal,09-06-2025
100029-8,Cancer related multigene analysis in Plasma cell-free DNA by Molecular genetics method,09-06-2025
100030-6,Axis I: Temporal aspects score [Mainz Pain Staging System],09-06-2025
100031-4,Axis II: Spatial aspects score [Mainz Pain Staging System],09-06-2025
10003-2,R wave duration in lead III,09-06-2025
100032-2,Axis III: Drug taking behavior score [Mainz Pain Staging System],09-06-2025
100033-0,Axis IV: Utilization of the health care system score [Mainz Pain Staging System],09-06-2025
100034-8,Provider of automated external defibrillator use,09-06-2025
100035-5,Exam finding location of Chest,09-06-2025
100036-3,Exam finding location of Lung,09-06-2025
100037-1,Patient contact disposition EMS unit,09-06-2025
100038-9,Patient evaluation disposition EMS unit,09-06-2025
100039-7,Crew disposition for patient care EMS unit,09-06-2025
10004-0,R wave duration in lead V1,09-06-2025
100040-5,Patient transport disposition EMS unit,09-06-2025
100041-3,Aminoglycoside [Susceptibility],09-06-2025
100042-1,Atovaquone [Susceptibility],09-06-2025
100043-9,Azithromycin+Ethambutol [Susceptibility],09-06-2025
100044-7,Cefcapene [Susceptibility],09-06-2025
100045-4,Cefozopran [Susceptibility],09-06-2025
100046-2,Cefquinome [Susceptibility],09-06-2025
100047-0,Cefteram [Susceptibility],09-06-2025
100048-8,Clarithromycin+Ethambutol [Susceptibility],09-06-2025
100049-6,Eravacycline [Susceptibility],09-06-2025
100050-4,Erythromycin+Ethambutol [Susceptibility],09-06-2025
100051-2,Ethambutol+rifAMPin [Susceptibility],09-06-2025
100052-0,Flomoxef [Susceptibility],09-06-2025
100053-8,Fluoroquinolone [Susceptibility],09-06-2025
100054-6,Gamithromycin [Susceptibility],09-06-2025
100055-3,Optochin [Susceptibility],09-06-2025
100056-1,Panipenem [Susceptibility],09-06-2025
10005-7,R wave duration in lead V2,09-06-2025
100057-9,Prothionamide [Susceptibility],09-06-2025
100058-7,Prulifloxacin [Susceptibility],09-06-2025
100059-5,Rifapentine [Susceptibility],09-06-2025
100060-3,Tildipirosin [Susceptibility],09-06-2025
100061-1,Tosufloxacin [Susceptibility],09-06-2025
100062-9,Standard Dermatology Outcome Measures panel,09-06-2025
100063-7,Primary skin concern,09-06-2025
100064-5,Itch severity Reporting Period - Reported,09-06-2025
10006-5,R wave duration in lead V3,09-06-2025
100065-2,Satisfied with treatment,09-06-2025
100066-0,Specular microscopy panel,09-06-2025
100067-8,Eye Image magnification,09-06-2025
100068-6,Right eye Fixation point [Angle],09-06-2025
100069-4,Left eye Fixation point [Angle],09-06-2025
100070-2,Right cornea Cell density,09-06-2025
100071-0,Left cornea Cell density,09-06-2025
100072-8,Right cornea Coefficient of variation,09-06-2025
10007-3,R wave duration in lead V4,09-06-2025
100073-6,Left cornea Coefficient of variation,09-06-2025
100074-4,Right cornea Hexagonality,09-06-2025
100075-1,Left cornea Hexagonality,09-06-2025
100076-9,Right cornea Endothelial cells counted,09-06-2025
100077-7,Left cornea Endothelial cells counted,09-06-2025
100078-5,Right cornea Endothelial cell area.min,09-06-2025
100079-3,Left cornea Endothelial cell area.min,09-06-2025
100080-1,Right cornea Endothelial cell area.max,09-06-2025
10008-1,R wave duration in lead V5,09-06-2025
100081-9,Left cornea Endothelial cell area.max,09-06-2025
100082-7,Right cornea Endothelial cell area.mean,09-06-2025
100083-5,Left cornea Endothelial cell area.mean,09-06-2025
100084-3,Right cornea Cell area.standard deviation,09-06-2025
100085-0,Left cornea Cell area.standard deviation,09-06-2025
100086-8,Right cornea Type of Analysis method by Specular microscopy,09-06-2025
100087-6,Toxocara canis 24-35kD IgG Ab [Presence] in Serum by Immunoblot,09-06-2025
100088-4,Taenia solium larva Ab bands panel - Serum by Immunoblot,09-06-2025
100089-2,Taenia solium larva 6-8kD Ab [Presence] in Serum by Immunoblot,09-06-2025
1000-9,DBG Ab [Presence] in Serum or Plasma from Blood product unit,09-06-2025
100090-0,Taenia solium larva 45kD Ab [Presence] in Serum by Immunoblot,09-06-2025
100091-8,Trypanosoma cruzi Ab [Units/volume] in Serum by Immunoassay,09-06-2025
100092-6,Trypanosoma cruzi Ab bands panel - Serum by Immunoblot,09-06-2025
100093-4,Trypanosoma cruzi 15-16kD IgG Ab [Presence] in Serum by Immunoblot,09-06-2025
100094-2,Trypanosoma cruzi 21-22kD IgG Ab [Presence] in Serum by Immunoblot,09-06-2025
100095-9,Trypanosoma cruzi 27-28kD IgG Ab [Presence] in Serum by Immunoblot,09-06-2025
100096-7,Trypanosoma cruzi 42kD IgG Ab [Presence] in Serum by Immunoblot,09-06-2025
100097-5,Trypanosoma cruzi 45-47kD IgG Ab [Presence] in Serum by Immunoblot,09-06-2025
100098-3,Trypanosoma cruzi 120-200kD IgG Ab [Presence] in Serum by Immunoblot,09-06-2025
10009-9,R wave duration in lead V6,09-06-2025
100099-1,Trypanosoma cruzi 160kD IgG Ab [Presence] in Serum by Immunoblot,09-06-2025
100100-7,Fasciola sp IgG Ab [Presence] in Serum by Immunoassay,09-06-2025
100101-5,Fasciola sp 8-9kD IgG Ab [Presence] in Serum by Immunoblot,09-06-2025
100102-3,Fasciola sp 27-28kD IgG Ab [Presence] in Serum by Immunoblot,09-06-2025
100103-1,Fasciola sp 60kD IgG Ab [Presence] in Serum by Immunoblot,09-06-2025
100104-9,Fasciola sp 42kD IgG Ab [Presence] in Serum by Immunoblot,09-06-2025
100105-6,Filaria IgG and IgM panel - Serum,09-06-2025
100106-4,Filaria IgG Ab [Presence] in Serum by Immunoassay,09-06-2025
10010-7,R' wave amplitude in lead AVF,09-06-2025
100107-2,Leishmania sp IgG Ab [Presence] in Serum by Immunoassay,09-06-2025
100108-0,Leishmania sp IgG Ab [Units/volume] in Serum by Immunoassay,09-06-2025
100109-8,Leishmania sp Ab bands panel - Serum by Immunoblot,09-06-2025
100110-6,Leishmania sp 14kD IgG Ab [Presence] in Serum by Immunoblot,09-06-2025
100111-4,Leishmania sp 16kD IgG Ab [Presence] in Serum by Immunoblot,09-06-2025
100112-2,Fasciola sp Ab bands panel - Serum by Immunoblot,09-06-2025
100113-0,Helicobacter pylori Ab panel - Serum,09-06-2025
100114-8,Toxoplasma gondii 30kD Ab [Presence] in Serum by Immunoblot,09-06-2025
10011-5,R' wave amplitude in lead AVL,09-06-2025
100115-5,Toxoplasma gondii 31kD Ab [Presence] in Serum by Immunoblot,09-06-2025
100116-3,Toxoplasma gondii 33kD Ab [Presence] in Serum by Immunoblot,09-06-2025
100117-1,Toxoplasma gondii 40kD Ab [Presence] in Serum by Immunoblot,09-06-2025
100118-9,Toxoplasma gondii 41kD Ab [Presence] in Serum by Immunoblot,09-06-2025
100119-7,Toxoplasma gondii 45kD Ab [Presence] in Serum by Immunoblot,09-06-2025
100120-5,Chlamydia trachomatis Ab panel - Serum,09-06-2025
100121-3,Chlamydia trachomatis IgA Ab [Presence] in Serum by Immunoassay,09-06-2025
100122-1,Chlamydophila pneumoniae Ab panel - Serum,09-06-2025
10012-3,R' wave amplitude in lead AVR,09-06-2025
100123-9,Chlamydophila pneumoniae IgA Ab [Presence] in Serum by Immunoassay,09-06-2025
100124-7,Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum by Immunoassay,09-06-2025
100125-4,Chlamydophila psittaci Ab panel - Serum,09-06-2025
100126-2,Bordetella pertussis Ab.IgG panel - Serum,09-06-2025
100127-0,Campylobacter sp Ab panel - Serum,09-06-2025
100128-8,Cryptococcus sp Ag panel - Serum,09-06-2025
100129-6,Schistosoma sp Ab [Titer] in Serum by Hemagglutination,09-06-2025
100130-4,Schistosoma mansoni Ab [Presence] in Serum by Immunoblot,09-06-2025
10013-1,R' wave amplitude in lead I,09-06-2025
100131-2,Schistosoma sp 8kD Ab [Presence] in Serum by Immunoblot,09-06-2025
100132-0,Schistosoma sp 9kD Ab [Presence] in Serum by Immunoblot,09-06-2025
100133-8,Schistosoma sp 10kD Ab [Presence] in Serum by Immunoblot,09-06-2025
100134-6,Schistosoma sp 11kD Ab [Presence] in Serum by Immunoblot,09-06-2025
100135-3,Schistosoma sp 12-13kD Ab [Presence] in Serum by Immunoblot,09-06-2025
100136-1,Schistosoma sp 14-15kD Ab [Presence] in Serum by Immunoblot,09-06-2025
100137-9,Schistosoma sp 15-16kD Ab [Presence] in Serum by Immunoblot,09-06-2025
100138-7,Schistosoma sp 18-19kD Ab [Presence] in Serum by Immunoblot,09-06-2025
100139-5,Schistosoma sp 22-24kD Ab [Presence] in Serum by Immunoblot,09-06-2025
100140-3,Schistosoma sp 30-34kD Ab [Presence] in Serum by Immunoblot,09-06-2025
100141-1,Schistosoma sp 65kD Ab [Presence] in Serum by Immunoblot,09-06-2025
100142-9,Schistosoma sp 70kD Ab [Presence] in Serum by Immunoblot,09-06-2025
100143-7,Schistosoma sp 80kD Ab [Presence] in Serum by Immunoblot,09-06-2025
100144-5,Schistosoma sp 95kD Ab [Presence] in Serum by Immunoblot,09-06-2025
100145-2,Schistosoma sp 110kD Ab [Presence] in Serum by Immunoblot,09-06-2025
100146-0,Schistosoma sp 120kD Ab [Presence] in Serum by Immunoblot,09-06-2025
100147-8,Toxoplasma gondii Ab bands panel - Serum by Immunoblot,09-06-2025
100148-6,Schistosoma sp Ab bands panel - Serum by Immunoblot,09-06-2025
10014-9,R' wave amplitude in lead II,09-06-2025
100149-4,6-oxo-piperidine-2-carboxylate and 6(R+S)-oxo-propylpiperidine-2-carboxylate panel - Urine and Serum or Plasma,09-06-2025
100150-2,6(R+S)-oxo-propylpiperidine-2-carboxylate [Moles/volume] in Plasma,09-06-2025
100151-0,6-oxo-piperidine-2-carboxylate [Moles/volume] in Plasma,09-06-2025
100152-8,6-oxo-piperidine-2-carboxylate/Creatinine [Molar ratio] in Urine,09-06-2025
100153-6,6(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine [Molar ratio] in Urine,09-06-2025
100154-4,Specimen collection supervision level,09-06-2025
100155-1,Left cornea Type of Analysis method by Specular microscopy,09-06-2025
10015-6,R' wave amplitude in lead III,09-06-2025
100156-9,SARS-CoV-2 (COVID-19) variant [Type] in Specimen by NAA with probe detection,09-06-2025
100157-7,SARS-CoV-2 (COVID-19) lineage [Type] in Specimen by Sequencing,09-06-2025
100158-5,Microalbumin [Mass/volume] in Urine collected for unspecified duration,09-06-2025
100159-3,Knee Society Score pre-op panel [Knee Society Score],09-06-2025
100160-1,Knee replacement,09-06-2025
100161-9,Charnley Functional Classification,09-06-2025
100162-7,Knee alignment W standing X-ray measured,09-06-2025
100163-5,Knee medial AndOr lateral instability W full extension,09-06-2025
10016-4,R' wave amplitude in lead V1,09-06-2025
100164-3,Knee AP instability W 90 degree flexion,09-06-2025
100165-0,Knee range of motion,09-06-2025
100166-8,Flexion contracture range of Knee,09-06-2025
100167-6,Extensor lag range of Knee,09-06-2025
100168-4,Knee pain severity with level walking,09-06-2025
100169-2,Knee pain severity with stairs or inclines,09-06-2025
1001-7,DBG Ab [Presence] in Serum or Plasma from Donor,09-06-2025
100170-0,Knee feels normal,09-06-2025
100171-8,Satisfaction with level of knee pain while sitting,09-06-2025
10017-2,R' wave amplitude in lead V2,09-06-2025
100172-6,Satisfaction with level of knee pain while lying in bed,09-06-2025
100173-4,Satisfaction with knee function while getting out of bed,09-06-2025
100174-2,Satisfaction with knee function while performing light household duties,09-06-2025
100175-9,Satisfaction with knee function while performing recreational activities,09-06-2025
100176-7,Expect surgery to relieve pain,09-06-2025
100177-5,Expect surgery will improve ability to perform activities of daily living,09-06-2025
100178-3,"Expect surgery will improve ability to perform leisure, recreational, or sports activities",09-06-2025
100179-1,Walk without assistive mobility devices,09-06-2025
10018-0,R' wave amplitude in lead V3,09-06-2025
100180-9,Assistive mobility devices used,09-06-2025
100181-7,Assistive mobility devices used due to health condition,09-06-2025
100182-5,Duration of standing before sitting due to knee discomfort,09-06-2025
100183-3,Duration of walking before stopping due to knee discomfort,09-06-2025
100184-1,How bothersome is knee when walking on an uneven surface,09-06-2025
100185-8,How bothersome is knee when turning or pivoting leg,09-06-2025
100186-6,How bothersome is knee when climbing up or down a flight of stairs,09-06-2025
100187-4,How bothersome is knee when getting up from a low seat without armrests,09-06-2025
100188-2,How bothersome is knee when getting into or out of a car,09-06-2025
100189-0,How bothersome is knee when moving laterally,09-06-2025
100190-8,How bothersome is knee when climbing a ladder or step stool,09-06-2025
100191-6,How bothersome is knee when carrying a bag for one block,09-06-2025
100192-4,How bothersome is knee when squatting,09-06-2025
100193-2,How bothersome is knee when kneeling,09-06-2025
100194-0,How bothersome is knee when running,09-06-2025
100195-7,Pain severity--during activity,09-06-2025
100196-5,Pre-op total score [Knee Society Score],09-06-2025
100197-3,Exercise activity and pain severity panel,09-06-2025
10019-8,R' wave amplitude in lead V4,09-06-2025
100198-1,Pre-op objective knee indicators score [Knee Society Score],09-06-2025
100199-9,Pre-op symptoms score [Knee Society Score],09-06-2025
100200-5,Pre-op patient expectations score [Knee Society Score],09-06-2025
100201-3,Pre-op functional activities score [Knee Society Score],09-06-2025
100202-1,Pre-op discretionary knee activities score [Knee Society Score],09-06-2025
100203-9,Knee Society Score post-op panel [Knee Society Score],09-06-2025
100204-7,Accuracy of pre-surgery expectations of pain relief,09-06-2025
100205-4,Accuracy of pre-surgery expectations to perform activities of daily living,09-06-2025
10020-6,R' wave amplitude in lead V5,09-06-2025
100206-2,"Accuracy of pre-surgery expectations to perform leisure, recreational, or sports activities",09-06-2025
100207-0,Post-op total score [Knee Society Score],09-06-2025
100208-8,Post-op objective knee indicators score [Knee Society Score],09-06-2025
100209-6,Post-op symptoms score [Knee Society Score],09-06-2025
100210-4,Post-op patient expectations score [Knee Society Score],09-06-2025
100211-2,Post-op functional activities score [Knee Society Score],09-06-2025
100212-0,Post-op discretionary knee activities score [Knee Society Score],09-06-2025
100213-8,Prostate cancer multigene analysis in Blood or Tissue by Molecular genetics method,09-06-2025
10021-4,R' wave amplitude in lead V6,09-06-2025
100214-6,Dental model prior authorization Document,09-06-2025
100215-3,Episode of care medical records Document Transplant surgery,09-06-2025
100216-1,Surgical synoptic report,09-06-2025
100217-9,Synoptic report Document Surgical oncology,09-06-2025
100218-7,Surgical oncology of colon cancer synoptic report,09-06-2025
100219-5,Surgical oncology of melanoma cancer synoptic report,09-06-2025
100220-3,Surgical oncology of breast cancer synoptic report,09-06-2025
100221-1,Surgical oncology of thyroid cancer synoptic report,09-06-2025
10022-2,R' wave duration in lead AVF,09-06-2025
100222-9,Surgical oncology of pancreas cancer synoptic report,09-06-2025
100223-7,Physical findings of Retina Narrative,09-06-2025
100224-5,Cardiac left ventricular segmental wall motion by echo panel,09-06-2025
100225-2,Bone density quantitative ultrasound study,09-06-2025
100226-0,Small bowel capsule endoscopy study Document,09-06-2025
100227-8,Colon capsule endoscopy study Document,09-06-2025
100228-6,Upper gastrointestinal capsule endoscopy study Document,09-06-2025
100229-4,Endoscopic ultrasound study Document,09-06-2025
10023-0,R' wave duration in lead AVL,09-06-2025
100230-2,Routine prenatal assessment panel,09-06-2025
100231-0,Endobronchial ultrasound study,09-06-2025
100232-8,Impacts of Events Scale-Revised panel,09-06-2025
100233-6,Reminders brought back feelings about adverse event,09-06-2025
100234-4,Trouble staying asleep,09-06-2025
100235-1,Other things triggered persistent thoughts about adverse event,09-06-2025
100236-9,Felt irritable AndOr angry,09-06-2025
100237-7,Avoided getting upset when unintentionally thought about adverse event,09-06-2025
100238-5,Thought about adverse event unintentionally,09-06-2025
100239-3,Felt as if adverse event did not happen,09-06-2025
100240-1,Avoided reminders of adverse event,09-06-2025
100241-9,Experienced mental images of adverse event,09-06-2025
100242-7,Easily startled,09-06-2025
100243-5,Tried to not think of adverse event,09-06-2025
100244-3,"Aware of feelings about adverse event, but did not address them",09-06-2025
100245-0,Feelings about adverse event were numb,09-06-2025
100246-8,Acted or felt the same as during adverse event,09-06-2025
100247-6,Trouble falling asleep,09-06-2025
10024-8,R' wave duration in lead AVR,09-06-2025
100248-4,Waves of strong feelings about adverse event,09-06-2025
100249-2,Tried to remove adverse event from memory,09-06-2025
1002-5,DBG Ab [Presence] in Serum or Plasma,09-06-2025
100250-0,Trouble concentrating,09-06-2025
100251-8,Reminders of adverse event caused physical reactions,09-06-2025
100252-6,Had dreams about adverse event,09-06-2025
100253-4,Felt watchful and on-guard,09-06-2025
100254-2,Tried not to talk about adverse event,09-06-2025
10025-5,R' wave duration in lead I,09-06-2025
100255-9,Total score [Impact of Event Scale-Revised],09-06-2025
100256-7,Fallen in last 6 months,09-06-2025
100257-5,Feel unsteady when standing or walking,09-06-2025
100258-3,History of fall related injury,09-06-2025
100259-1,Aware of tactile sensations,09-06-2025
100260-9,Easy to describe thoughts AndOr feelings,09-06-2025
100261-7,Critical of own thoughts AndOr feelings,09-06-2025
100262-5,Able to notice distressing thoughts AndOr feelings without having to react,09-06-2025
10026-3,R' wave duration in lead II,09-06-2025
100263-3,Easily distracted,09-06-2025
100264-1,Able to notice thoughts AndOr feelings without being overwhelmed,09-06-2025
100265-8,Aware of dietary intake impact on self,09-06-2025
100266-6,Difficult to describe thoughts AndOr feelings,09-06-2025
100267-4,Aware of auditory stimuli,09-06-2025
100268-2,Able to avoid immediate reaction in difficult situations,09-06-2025
100269-0,Do things without paying attention,09-06-2025
100270-8,Recover quickly from distressing thoughts AndOr images,09-06-2025
10027-1,R' wave duration in lead III,09-06-2025
100271-6,Aware of olfactory stimuli,09-06-2025
100272-4,Aware of visual stimuli,09-06-2025
100273-2,Aware of emotions affect on thoughts AndOr behavior,09-06-2025
100274-0,Observing score [FFMQ],09-06-2025
100275-7,Describing score [FFMQ],09-06-2025
100276-5,Acting with awareness score [FFMQ],09-06-2025
100277-3,Nonjudging score [FFMQ],09-06-2025
100278-1,Nonreactivity score [FFMQ],09-06-2025
100279-9,Total score [FFMQ],09-06-2025
100280-7,Five Facet Mindfulness Questionnaire panel [FFMQ],09-06-2025
100281-5,D Ab [Units/volume] in Serum or Plasma,09-06-2025
100282-3,Vaccine exemption certificate,09-06-2025
100283-1,Harris Hip Score panel [Harris Hip Score],09-06-2025
100284-9,Walking - functional ability,09-06-2025
100285-6,Comfortable seated position,09-06-2025
100286-4,Able to board public transportation,09-06-2025
100287-2,Put on shoes and socks,09-06-2025
100288-0,Absence of deformity score [Harris Hip Score],09-06-2025
10028-9,R' wave duration in lead V1,09-06-2025
100289-8,Absence of hip deformity measurements,09-06-2025
100290-6,Range of motion score [Harris Hip Score],09-06-2025
100291-4,Total score [Harris Hip Score],09-06-2025
100292-2,Pre-op patient satisfaction score [Knee Society Score],09-06-2025
100293-0,Hip Flexion range of motion,09-06-2025
100294-8,Hip Abduction range of motion,09-06-2025
100295-5,Hip Adduction range of motion,09-06-2025
100296-3,Hip External rotation range of motion,09-06-2025
10029-7,R' wave duration in lead V2,09-06-2025
100297-1,Hip Internal rotation range of motion,09-06-2025
100298-9,Repetition count,09-06-2025
100299-7,Post-op patient satisfaction score [Knee Society Score],09-06-2025
100300-3,End time Unspecified body region,09-06-2025
100301-1,Start time Unspecified body region,09-06-2025
100302-9,Time period start and end panel Unspecified body region,09-06-2025
100303-7,Condition certainty of presence,09-06-2025
100304-5,Flights climbed [#] Reporting Period,09-06-2025
10030-5,R' wave duration in lead V3,09-06-2025
100305-2,IDH1 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method,09-06-2025
100306-0,IDH2 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method,09-06-2025
100307-8,Behavioral screening elder mistreatment,09-06-2025
100308-6,Need help getting to essential places,09-06-2025
100309-4,Activity support person,09-06-2025
100310-2,Reliability of support person,09-06-2025
100311-0,"Need help to make sure there is enough food, medicines or any other things needed in house",09-06-2025
100312-8,"Person or persons that makes sure there is enough food, medicines or any other things needed in house",09-06-2025
10031-3,R' wave duration in lead V4,09-06-2025
100313-6,"Need help with household things such as cook meals, help feed, or provide correct medicines each day",09-06-2025
100314-4,Need help with house cleaning or yard work,09-06-2025
100315-1,"Need help getting out of bed, showered, or dressed",09-06-2025
100316-9,Need help to make sure bills get paid,09-06-2025
100317-7,Relationship of usual support person for daily activities,09-06-2025
100318-5,Have help with finances AndOr financial decisions,09-06-2025
100319-3,Relationship of financial support person,09-06-2025
100320-1,Financial support person usually asks for permission before making decisions,09-06-2025
10032-1,R' wave duration in lead V5,09-06-2025
100321-9,Financial support person usually makes good decisions about finances,09-06-2025
100322-7,Have access to paperwork for financial decisions made,09-06-2025
100323-5,Financial support person forged signature,09-06-2025
100324-3,Coercion of financial support person for signing a document in order to get money or possessions,09-06-2025
100325-0,Experienced theft by support person,09-06-2025
100326-8,Money spent or property sold without permission,09-06-2025
100327-6,Stranger forged signature for financial gain,09-06-2025
100328-4,Stranger forced document signature for financial gain,09-06-2025
100329-2,Feared for safety due to verbal attack,09-06-2025
1003-3,Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma,09-06-2025
100330-0,Felt humiliated due to ridicule,09-06-2025
100331-8,Coerced to do something,09-06-2025
100332-6,Ignored by close friend or relative for extended period,09-06-2025
100333-4,Physically hit or threatened,09-06-2025
100334-2,Been physically hurt with some degree of injury,09-06-2025
100335-9,Coerced sexual activity,09-06-2025
100336-7,Coerced touching of private body parts of self or others,09-06-2025
100337-5,Coerced to undress or expose private body area,09-06-2025
100338-3,Photographed in any degree of nudity without consent,09-06-2025
10033-9,R' wave duration in lead V6,09-06-2025
100339-1,Experienced attempted physical restraint,09-06-2025
100340-9,Range of motion panel Hip,09-06-2025
100341-7,Rubella virus IgG Ab index [Units/volume] in Serum and CSF,09-06-2025
100342-5,Volatile Organic Compounds associated with SARS-CoV-2 infection [Presence] in Exhaled gas by Gas chromatography-mass spectrometry,09-06-2025
100343-3,Influenza virus B RNA [Presence] in Saliva (oral fluid) by NAA with probe detection,09-06-2025
100344-1,Influenza virus A RNA [Presence] in Saliva (oral fluid) by NAA with probe detection,09-06-2025
100345-8,Influenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection,09-06-2025
100346-6,Clotting time.extrinsic coagulation system activated.platelets inhibited of Blood by Rotational TEG,09-06-2025
10034-7,S wave amplitude in lead AVF,09-06-2025
100347-4,Clot formation.extrinsic coagulation system activated.platelets inhibited [Time] in Blood by Rotational TEG,09-06-2025
100348-2,Model for end-stage liver disease sodium score,09-06-2025
100349-0,US.doppler Penis vessels W vasodilator IV,09-06-2025
100350-8,Sesamum indicum 1 IgE Ab [Units/volume] in Serum,09-06-2025
100351-6,Pioglitazone [Presence] in Serum or Plasma,09-06-2025
100352-4,Rosiglitazone [Presence] in Serum or Plasma,09-06-2025
100353-2,Norwalk Community Health Center Screening Tool [NCHC],09-06-2025
10035-4,S wave amplitude in lead AVL,09-06-2025
100354-0,Frequency of participating in multi-modal communication without assistance,09-06-2025
100355-7,Frequency of participating in spoken language expression communication without assistance,09-06-2025
100356-5,Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA [Identifier] in Specimen by NAA with probe detection,09-06-2025
100357-3,Naloxone [Presence] in Cord tissue by Screen method,09-06-2025
100358-1,Phentermine [Presence] in Cord tissue by Screen method,09-06-2025
100359-9,Gliadin 33 mer peptide [Mass/volume] in Stool by Immunoassay,09-06-2025
100360-7,Brief Resilience Scale panel [BRS],09-06-2025
100361-5,Quickly recover from bad events,09-06-2025
10036-2,S wave amplitude in lead AVR,09-06-2025
100362-3,Difficulty making it through stressful events,09-06-2025
100363-1,Easily recover from a stressful event,09-06-2025
100364-9,Difficulty recovering from bad events,09-06-2025
100365-6,Easily recover from difficulties,09-06-2025
100366-4,Lengthy recovery from setbacks,09-06-2025
100367-2,Total Score BRS,09-06-2025
100368-0,Amino Acids Urea Cycle Panel - Serum or Plasma by LC/MS/MS,09-06-2025
100369-8,NM Thyroid gland Views W Tl-201 IV,09-06-2025
10037-0,S wave amplitude in lead I,09-06-2025
100370-6,Orthopoxvirus DNA [Identifier] in Specimen by NAA with probe detection,09-06-2025
100371-4,Titin Ab [Units/volume] in Serum by Immunoassay,09-06-2025
100372-2,Abiraterone [Mass/volume] in Serum or Plasma,09-06-2025
100373-0,Eucheuma IgG Ab [Units/volume] in Serum,09-06-2025
100374-8,Aloe vera IgG Ab [Units/volume] in Serum,09-06-2025
100375-5,Anise IgG Ab [Units/volume] in Serum,09-06-2025
100376-3,Bamboo sprouts IgG Ab [Units/volume] in Serum,09-06-2025
100377-1,Goat cheese IgG Ab [Units/volume] in Serum,09-06-2025
100378-9,Sheep cheese IgG Ab [Units/volume] in Serum,09-06-2025
100379-7,Leeks IgG Ab [Units/volume] in Serum,09-06-2025
100380-5,Red cabbage IgG Ab [Units/volume] in Serum,09-06-2025
100381-3,Peppermint IgG Ab [Units/volume] in Serum,09-06-2025
100382-1,FDA package insert REMS addressed risk,09-06-2025
100383-9,Monkeypox virus DNA [Presence] in Specimen by NAA with probe detection,09-06-2025
100384-7,Turnip IgG Ab [Units/volume] in Serum,09-06-2025
100385-4,Corn salad IgG Ab [Units/volume] in Serum,09-06-2025
100386-2,Rosemary IgG Ab [Units/volume] in Serum,09-06-2025
100387-0,Poppy Seed IgG Ab [Units/volume] in Serum,09-06-2025
10038-8,S wave amplitude in lead II,09-06-2025
100388-8,Cocoa IgG Ab [Units/volume] in Serum,09-06-2025
100389-6,Pistachio IgG Ab [Units/volume] in Serum,09-06-2025
100390-4,Sunflower Seed IgG Ab [Units/volume] in Serum,09-06-2025
100391-2,Dates IgG Ab [Units/volume] in Serum,09-06-2025
100392-0,Duck meat IgG Ab [Units/volume] in Serum,09-06-2025
100393-8,"Allergen Mushroom mix 2 (Xerocomus, Boletus) IgG Ab [Units/volume] in Serum",09-06-2025
100394-6,Astacoidea IgG Ab [Units/volume] in Serum,09-06-2025
100395-3,Carob IgG Ab [Units/volume] in Serum,09-06-2025
10039-6,S wave amplitude in lead III,09-06-2025
100396-1,Rapeseed IgG Ab [Units/volume] in Serum,09-06-2025
100397-9,Goat Meat IgG Ab [Units/volume] in Serum,09-06-2025
100398-7,Goose meat IgG Ab [Units/volume] in Serum,09-06-2025
100399-5,Ostrich meat IgG Ab [Units/volume] in Serum,09-06-2025
100400-1,Quail meat IgG Ab [Units/volume] in Serum,09-06-2025
100401-9,Rabbit meat IgG Ab [Units/volume] in Serum,09-06-2025
100402-7,Venison meat IgG Ab [Units/volume] in Serum,09-06-2025
100403-5,Guineafowl IgG Ab [Units/volume] in Serum,09-06-2025
10040-4,S wave amplitude in lead V1,09-06-2025
100404-3,Horse meat IgG Ab [Units/volume] in Serum,09-06-2025
100405-0,Kefir IgG Ab [Units/volume] in Serum,09-06-2025
100406-8,Butter IgG Ab [Units/volume] in Serum,09-06-2025
100407-6,Camembert cheese IgG Ab [Units/volume] in Serum,09-06-2025
100408-4,Emmental cheese IgG Ab [Units/volume] in Serum,09-06-2025
100409-2,Processed cheese IgG Ab [Units/volume] in Serum,09-06-2025
1004-1,Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells,09-06-2025
100410-0,Curd cheese IgG Ab [Units/volume] in Serum,09-06-2025
100411-8,Sugar Beet IgG Ab [Units/volume] in Serum,09-06-2025
10041-2,S wave amplitude in lead V2,09-06-2025
100412-6,Chinese cabbage IgG Ab [Units/volume] in Serum,09-06-2025
100413-4,Fennel Fresh IgG Ab [Units/volume] in Serum,09-06-2025
100414-2,Gourd IgG Ab [Units/volume] in Serum,09-06-2025
100415-9,Kale IgG Ab [Units/volume] in Serum,09-06-2025
100416-7,Savoy cabbage IgG Ab [Units/volume] in Serum,09-06-2025
100417-5,Vitis sp leaf IgG Ab [Units/volume] in Serum,09-06-2025
100418-3,Liquorice IgG Ab [Units/volume] in Serum,09-06-2025
100419-1,Snow pea IgG Ab [Units/volume] in Serum,09-06-2025
10042-0,S wave amplitude in lead V3,09-06-2025
100420-9,Fava bean IgG Ab [Units/volume] in Serum,09-06-2025
100421-7,Chickpea IgG Ab [Units/volume] in Serum,09-06-2025
100422-5,Common Chicory IgG Ab [Units/volume] in Serum,09-06-2025
100423-3,Allergy Mushroom Mix 1 (Button + oyster + Shiitaki + chanterelle mushroom) IgG Ab [Units/volume] in Serum,09-06-2025
100424-1,8(9)-Cholestenol [Mass/volume] in Serum or Plasma,09-06-2025
100425-8,DiHydro T-Mas [Mass/volume] in Serum or Plasma,09-06-2025
100426-6,Squalene [Mass/volume] in Serum or Plasma,09-06-2025
100427-4,Stigmasterol [Mass/volume] in Serum or Plasma,09-06-2025
100428-2,Carnitine free and total and acylcarnitine panel - Urine,09-06-2025
100429-0,LRBA deficiency panel - Blood,09-06-2025
100430-8,Cells.LRBA+/Cells.CD3+CD14-CD45+ in Blood by Flow cytometry (FC),09-06-2025
100431-6,Cells.CD3+CD14-CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC),09-06-2025
100432-4,Cells.LRBA+/Cells.CD3-CD14-CD19+CD45+ in Blood by Flow cytometry (FC),09-06-2025
100433-2,Cells.CD3-CD14-CD19+CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC),09-06-2025
100434-0,Orthopoxvirus.non-variola DNA [Presence] in Specimen by NAA with probe detection,09-06-2025
100435-7,Glial fibrillary acidic protein [Mass/volume] in Serum by Immunoassay,09-06-2025
100436-5,Ubiquitin carboxyl-terminal hydrolase-L1 [Mass/volume] in Serum by Immunoassay,09-06-2025
100437-3,Norsufentanil [Mass/volume] in Urine by Confirmatory method,09-06-2025
10043-8,S wave amplitude in lead V4,09-06-2025
100438-1,Adolescent medicine Outpatient Progress note,09-06-2025
100439-9,Allergy and Immunology Outpatient Progress note,09-06-2025
100440-7,Allergy Outpatient Progress note,09-06-2025
100441-5,Attending Outpatient Progress note,09-06-2025
100442-3,Audiology Outpatient Progress note,09-06-2025
100443-1,Bariatric surgery Outpatient Progress note,09-06-2025
100444-9,Blood banking and transfusion medicine Outpatient Progress note,09-06-2025
100445-6,Bone Marrow Transplant Outpatient Progress note,09-06-2025
10044-6,S wave amplitude in lead V5,09-06-2025
100446-4,Breastfeeding Outpatient Progress note,09-06-2025
100447-2,Burn management Outpatient Progress note,09-06-2025
100448-0,Cardiac surgery Outpatient Progress note,09-06-2025
100449-8,Cardiopulmonary Outpatient Progress note,09-06-2025
100450-6,Child and adolescent psychiatry Outpatient Progress note,09-06-2025
100451-4,Chiropractic medicine Outpatient Progress note,09-06-2025
100452-2,Clinical cardiac electrophysiology Outpatient Progress note,09-06-2025
10045-3,S wave amplitude in lead V6,09-06-2025
100453-0,Clinical genetics Outpatient Progress note,09-06-2025
100454-8,Clinical neurophysiology Outpatient Progress note,09-06-2025
100455-5,Clinical pathology Outpatient Progress note,09-06-2025
100456-3,Colon and rectal surgery Outpatient Progress note,09-06-2025
100457-1,Consultant Outpatient Progress note,09-06-2025
100458-9,Outpatient COVID-19 Intubation Progress note,09-06-2025
100459-7,Outpatient COVID-19 Progress note,09-06-2025
100460-5,Dermatology Outpatient Progress note,09-06-2025
10046-1,S wave duration in lead AVF,09-06-2025
100461-3,Developmental-behavioral pediatrics Outpatient Progress note,09-06-2025
100462-1,Dialysis and Therapeutic apheresis Outpatient Progress note,09-06-2025
100463-9,Eating disorders Outpatient Progress note,09-06-2025
100464-7,Endocrinology Outpatient Progress note,09-06-2025
100465-4,Family medicine Outpatient Progress note,09-06-2025
100466-2,Gastroenterology Outpatient Progress note,09-06-2025
100467-0,Geriatric medicine Outpatient Progress note,09-06-2025
100468-8,Gynecologic oncology Outpatient Progress note,09-06-2025
100469-6,Gynecology Outpatient Progress note,09-06-2025
100470-4,Healthcare navigator Outpatient Progress note,09-06-2025
100471-2,Heart failure Outpatient Progress note,09-06-2025
100472-0,Heart failure+Transplant cardiology Outpatient Progress note,09-06-2025
100473-8,Hematology Outpatient Progress note,09-06-2025
100474-6,Hematology+Medical oncology Outpatient Progress note,09-06-2025
100475-3,Hepatology Outpatient Progress note,09-06-2025
100476-1,Immunology Outpatient Progress note,09-06-2025
100477-9,Infectious disease Outpatient Progress note,09-06-2025
100478-7,Internal medicine Outpatient Progress note,09-06-2025
10047-9,S wave duration in lead AVL,09-06-2025
100479-5,Interventional cardiology Outpatient Progress note,09-06-2025
100480-3,Interventional radiology Outpatient Progress note,09-06-2025
100481-1,Outpatient Mechanical circulatory support Progress note,09-06-2025
100482-9,Medical Aid in Dying Outpatient Progress note,09-06-2025
100483-7,Mental health Outpatient Progress note,09-06-2025
100484-5,Multi-specialty program Outpatient Progress note,09-06-2025
100485-2,Neonatal perinatal medicine Outpatient Progress note,09-06-2025
100486-0,Nephrology Outpatient Progress note,09-06-2025
10048-7,S wave duration in lead AVR,09-06-2025
100487-8,Neurological surgery Outpatient Progress note,09-06-2025
100488-6,Neurology Outpatient Progress note,09-06-2025
100489-4,Neurology with special qualifications in child neurology Outpatient Progress note,09-06-2025
100490-2,Nurse practitioner Outpatient Progress note,09-06-2025
100491-0,Nurse Outpatient Progress note,09-06-2025
100492-8,Nutrition and dietetics Outpatient Progress note,09-06-2025
100493-6,Obstetrics and Gynecology Outpatient Progress note,09-06-2025
100494-4,Obstetrics Outpatient Progress note,09-06-2025
10049-5,S wave duration in lead I,09-06-2025
100495-1,Occupational therapy Outpatient Progress note,09-06-2025
100496-9,Oncology Outpatient Progress note,09-06-2025
100497-7,Ophthalmology Outpatient Progress note,09-06-2025
100498-5,Optometry Outpatient Progress note,09-06-2025
100499-3,Oral and Maxillofacial Surgery Outpatient Progress note,09-06-2025
100500-8,Orthopaedic surgery Outpatient Progress note,09-06-2025
100501-6,Orthotics prosthetics Outpatient Progress note,09-06-2025
100502-4,Otolaryngology Outpatient Progress note,09-06-2025
10050-3,S wave duration in lead II,09-06-2025
100503-2,Pain medicine Outpatient Progress note,09-06-2025
100504-0,Palliative care Outpatient Progress note,09-06-2025
100505-7,Pediatric cardiology Outpatient Progress note,09-06-2025
100506-5,Pediatric dermatology Outpatient Progress note,09-06-2025
100507-3,Pediatric endocrinology Outpatient Progress note,09-06-2025
100508-1,Pediatric gastroenterology Outpatient Progress note,09-06-2025
100509-9,Pediatric hematology-oncology Outpatient Progress note,09-06-2025
100510-7,Pediatric infectious diseases Outpatient Progress note,09-06-2025
10051-1,S wave duration in lead III,09-06-2025
100511-5,Pediatric otolaryngology Outpatient Progress note,09-06-2025
100512-3,Pediatric pulmonology Outpatient Progress note,09-06-2025
100513-1,Pediatric rheumatology Outpatient Progress note,09-06-2025
100514-9,Pediatric surgery Outpatient Progress note,09-06-2025
100515-6,Pediatric transplant hepatology Outpatient Progress note,09-06-2025
100516-4,Pediatric urology Outpatient Progress note,09-06-2025
100517-2,Pharmacogenomics Outpatient Progress note,09-06-2025
100518-0,Physical medicine and rehab Outpatient Progress note,09-06-2025
100519-8,Physical therapy Outpatient Progress note,09-06-2025
100520-6,Plastic surgery Outpatient Progress note,09-06-2025
100521-4,Podiatry Outpatient Progress note,09-06-2025
100522-2,Psychiatry Hospital Progress note,09-06-2025
100523-0,Psychology Outpatient Progress note,09-06-2025
100524-8,Pulmonary Outpatient Progress note,09-06-2025
100525-5,Radiation oncology Outpatient Progress note,09-06-2025
100526-3,Radiology Outpatient Progress note,09-06-2025
100527-1,Recreational therapy Outpatient Progress note,09-06-2025
100528-9,Reproductive endocrinology and infertility Outpatient Progress note,09-06-2025
10052-9,S wave duration in lead V1,09-06-2025
100529-7,Research Outpatient Progress note,09-06-2025
100530-5,Rheumatology Outpatient Progress note,09-06-2025
100531-3,Sleep medicine Outpatient Progress note,09-06-2025
100532-1,Social worker Outpatient Progress note,09-06-2025
100533-9,Solid Organ Transplant Outpatient Progress note,09-06-2025
100534-7,Speech-language pathology Outpatient Progress note,09-06-2025
100535-4,Spinal surgery Outpatient Progress note,09-06-2025
100536-2,Sports medicine Outpatient Progress note,09-06-2025
10053-7,S wave duration in lead V2,09-06-2025
100537-0,Surgery of the hand Outpatient Progress note,09-06-2025
100538-8,Telehealth+Outpatient Progress note,09-06-2025
100539-6,Thromboembolism Outpatient Progress note,09-06-2025
100540-4,Transplant surgery Outpatient Progress note,09-06-2025
100541-2,Trauma Outpatient Progress note,09-06-2025
100542-0,Urology Outpatient Progress note,09-06-2025
100543-8,Vascular neurology Outpatient Progress note,09-06-2025
100544-6,Vascular surgery Outpatient Progress note,09-06-2025
10054-5,S wave duration in lead V3,09-06-2025
100545-3,Wound care management Outpatient Progress note,09-06-2025
100546-1,"Wound, Ostomy, and Continence Care Outpatient Progress note",09-06-2025
100547-9,Adolescent medicine Hospital Progress note,09-06-2025
100548-7,Allergy and Immunology Hospital Progress note,09-06-2025
100549-5,Allergy Hospital Progress note,09-06-2025
100550-3,Attending Hospital Progress note,09-06-2025
100551-1,Audiology Hospital Progress note,09-06-2025
10055-2,S wave duration in lead V4,09-06-2025
100552-9,Bariatric surgery Hospital Progress note,09-06-2025
100553-7,Blood banking and transfusion medicine Hospital Progress note,09-06-2025
100554-5,Bone Marrow Transplant Hospital Progress note,09-06-2025
100555-2,Breastfeeding Hospital Progress note,09-06-2025
100556-0,Burn management Hospital Progress note,09-06-2025
100557-8,Cardiac surgery Hospital Progress note,09-06-2025
100558-6,Cardiopulmonary Hospital Progress note,09-06-2025
100559-4,Child and adolescent psychiatry Hospital Progress note,09-06-2025
10056-0,S wave duration in lead V5,09-06-2025
100560-2,Clinical cardiac electrophysiology Hospital Progress note,09-06-2025
100561-0,Clinical genetics Hospital Progress note,09-06-2025
100562-8,Clinical neurophysiology Hospital Progress note,09-06-2025
100563-6,Clinical pathology Hospital Progress note,09-06-2025
100564-4,Colon and rectal surgery Hospital Progress note,09-06-2025
100565-1,Consultant Hospital Progress note,09-06-2025
100566-9,Dentistry Hospital Progress note,09-06-2025
100567-7,Dermatology Hospital Progress note,09-06-2025
100568-5,Developmental-behavioral pediatrics Hospital Progress note,09-06-2025
100569-3,Dialysis and Therapeutic apheresis Hospital Progress note,09-06-2025
100570-1,Eating disorders Hospital Progress note,09-06-2025
100571-9,Endocrinology Hospital Progress note,09-06-2025
100572-7,Family medicine Hospital Progress note,09-06-2025
100573-5,Gastroenterology Hospital Progress note,09-06-2025
100574-3,General medicine Hospital Progress note,09-06-2025
100575-0,Geriatric medicine Hospital Progress note,09-06-2025
100576-8,Gynecologic oncology Hospital Progress note,09-06-2025
100577-6,Gynecology Hospital Progress note,09-06-2025
10057-8,S wave duration in lead V6,09-06-2025
100578-4,Healthcare navigator Hospital Progress note,09-06-2025
100579-2,Heart failure Hospital Progress note,09-06-2025
1005-8,Indirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma,09-06-2025
100580-0,Heart failure+Transplant cardiology Hospital Progress note,09-06-2025
100581-8,Hematology Hospital Progress note,09-06-2025
100582-6,Hematology+Medical oncology Hospital Progress note,09-06-2025
100583-4,Hepatology Hospital Progress note,09-06-2025
100584-2,Immunology Hospital Progress note,09-06-2025
100585-9,Infectious disease Hospital Progress note,09-06-2025
10058-6,S' wave amplitude in lead AVF,09-06-2025
100586-7,Internal medicine Hospital Progress note,09-06-2025
100587-5,Interventional cardiology Hospital Progress note,09-06-2025
100588-3,Interventional radiology Hospital Progress note,09-06-2025
100589-1,Hospital Mechanical circulatory support Progress note,09-06-2025
100590-9,Medical Aid in Dying Hospital Progress note,09-06-2025
100591-7,Mental health Hospital Progress note,09-06-2025
100592-5,Multi-specialty program Hospital Progress note,09-06-2025
100593-3,Neonatal perinatal medicine Hospital Progress note,09-06-2025
10059-4,S' wave amplitude in lead AVL,09-06-2025
100594-1,Nephrology Hospital Progress note,09-06-2025
100595-8,Neurological surgery Hospital Progress note,09-06-2025
100596-6,Neurology Hospital Progress note,09-06-2025
100597-4,Neurology with special qualifications in child neurology Hospital Progress note,09-06-2025
100598-2,Nurse practitioner Hospital Progress note,09-06-2025
100599-0,Nurse Hospital Progress note,09-06-2025
100600-6,Nutrition and dietetics Hospital Progress note,09-06-2025
100601-4,Obstetrics and Gynecology Hospital Progress note,09-06-2025
10060-2,S' wave amplitude in lead AVR,09-06-2025
100602-2,Obstetrics Hospital Progress note,09-06-2025
100603-0,Occupational therapy Hospital Progress note,09-06-2025
100604-8,Oncology Hospital Progress note,09-06-2025
100605-5,Ophthalmology Hospital Progress note,09-06-2025
100606-3,Oral and Maxillofacial Surgery Hospital Progress note,09-06-2025
100607-1,Orthopaedic surgery Hospital Progress note,09-06-2025
100608-9,Orthotics prosthetics Hospital Progress note,09-06-2025
100609-7,Otolaryngology Hospital Progress note,09-06-2025
10061-0,S' wave amplitude in lead I,09-06-2025
100610-5,Pain medicine Hospital Progress note,09-06-2025
100611-3,Palliative care Hospital Progress note,09-06-2025
100612-1,Pastoral care Hospital Progress note,09-06-2025
100613-9,Pediatric cardiology Hospital Progress note,09-06-2025
100614-7,Pediatric dermatology Hospital Progress note,09-06-2025
100615-4,Pediatric endocrinology Hospital Progress note,09-06-2025
100616-2,Pediatric gastroenterology Hospital Progress note,09-06-2025
100617-0,Pediatric hematology-oncology Hospital Progress note,09-06-2025
100618-8,Pediatric infectious diseases Hospital Progress note,09-06-2025
100619-6,Pediatric otolaryngology Hospital Progress note,09-06-2025
100620-4,Pediatric pulmonology Hospital Progress note,09-06-2025
100621-2,Pediatric rheumatology Hospital Progress note,09-06-2025
100622-0,Pediatric surgery Hospital Progress note,09-06-2025
100623-8,Pediatric transplant hepatology Hospital Progress note,09-06-2025
100624-6,Pharmacogenomics Hospital Progress note,09-06-2025
100625-3,Pharmacology Hospital Progress note,09-06-2025
100626-1,Physical medicine and rehab Hospital Progress note,09-06-2025
100627-9,Physical therapy Hospital Progress note,09-06-2025
10062-8,S' wave amplitude in lead II,09-06-2025
100628-7,Plastic surgery Hospital Progress note,09-06-2025
100629-5,Podiatry Hospital Progress note,09-06-2025
100630-3,Psychology Hospital Progress note,09-06-2025
100631-1,Radiation oncology Hospital Progress note,09-06-2025
100632-9,Radiology Hospital Progress note,09-06-2025
100633-7,Rapid response team Hospital Progress note,09-06-2025
100634-5,Recreational therapy Hospital Progress note,09-06-2025
100635-2,Reproductive endocrinology and infertility Hospital Progress note,09-06-2025
10063-6,S' wave amplitude in lead III,09-06-2025
100636-0,Research Hospital Progress note,09-06-2025
100637-8,Rheumatology Hospital Progress note,09-06-2025
100638-6,Sleep medicine Hospital Progress note,09-06-2025
100639-4,Social worker Hospital Progress note,09-06-2025
100640-2,Solid Organ Transplant Hospital Progress note,09-06-2025
100641-0,Speech-language pathology Hospital Progress note,09-06-2025
100642-8,Spinal surgery Hospital Progress note,09-06-2025
100643-6,Surgery of the hand Hospital Progress note,09-06-2025
10064-4,S' wave amplitude in lead V1,09-06-2025
100644-4,Thromboembolism Hospital Progress note,09-06-2025
100645-1,Trauma Hospital Progress note,09-06-2025
100646-9,Urology Hospital Progress note,09-06-2025
100647-7,Vascular neurology Hospital Progress note,09-06-2025
100648-5,Vascular surgery Hospital Progress note,09-06-2025
100649-3,Wound care management Hospital Progress note,09-06-2025
100650-1,"Wound, Ostomy, and Continence Care Hospital Progress note",09-06-2025
10065-1,S' wave amplitude in lead V2,09-06-2025
100651-9,Hospital COVID-19 Intubation Progress note,09-06-2025
100652-7,Pure tone bone conduction threshold audiometry panel,09-06-2025
100653-5,Pure tone air conduction threshold audiometry panel,09-06-2025
100654-3,Pyruvate kinase M2 [Presence] in Stool,09-06-2025
100655-0,XR Sella turcica Lateral,09-06-2025
100656-8,Maternal and fetal medicine Outpatient Progress note,09-06-2025
100657-6,Maternal and fetal medicine Telephone encounter+Hospital Progress note,09-06-2025
100658-4,Hospital COVID-19 Progress note,09-06-2025
100659-2,Maternal and fetal medicine Hospital Progress note,09-06-2025
1006-6,Direct antiglobulin test.IgG specific reagent [Interpretation] on Red Blood Cells,09-06-2025
100660-0,Maternal and fetal medicine Telephone encounter+Outpatient Progress note,09-06-2025
100661-8,Psychiatry Outpatient Progress note,09-06-2025
100662-6,Cortisol free and total panel - Serum or Plasma,09-06-2025
100663-4,TPMT gene c.460G>A and c.719A>G [Presence] in Blood by Molecular genetics method,09-06-2025
100664-2,NUDT15 gene c.50_55dup and c.415C>T [Presence] in Blood by Molecular genetics method,09-06-2025
100665-9,NUDT15 gene c.415C>T [Presence] in Blood by Molecular genetics method,09-06-2025
100666-7,NUDT15 gene c.416G>A [Presence] in Blood by Molecular genetics method,09-06-2025
100667-5,NUDT15 gene c.52G>A [Presence] in Blood by Molecular genetics method,09-06-2025
100668-3,NUDT15 gene c.50_55dup [Presence] in Blood by Molecular genetics method,09-06-2025
10066-9,S' wave amplitude in lead V3,09-06-2025
100669-1,NUDT15 gene c.50_55del [Presence] in Blood by Molecular genetics method,09-06-2025
100670-9,RHD gene allele [Identifier] in Plasma cell-free DNA Nominal--fetus,09-06-2025
100671-7,Aspergillus sp DNA [Presence] in Blood by NAA with probe detection,09-06-2025
100672-5,Aspergillus fumigatus DNA [Presence] in Blood by NAA with probe detection,09-06-2025
100673-3,Aspergillus terreus DNA [Presence] in Blood by NAA with probe detection,09-06-2025
100674-1,BK virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection,09-06-2025
100675-8,Cytomegalovirus DNA [Units/volume] (viral load) in Blood by NAA with probe detection,09-06-2025
100676-6,Cytomegalovirus DNA [log units/volume] (viral load) in Blood by NAA with probe detection,09-06-2025
10067-7,S' wave amplitude in lead V4,09-06-2025
100677-4,Epstein Barr virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,09-06-2025
100678-2,Epstein Barr virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection,09-06-2025
100679-0,Herpes virus 6 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,09-06-2025
100680-8,Herpes virus 6 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection,09-06-2025
100681-6,Herpes virus 7 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,09-06-2025
100682-4,Herpes virus 7 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection,09-06-2025
100683-2,Herpes virus 8 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,09-06-2025
100684-0,Herpes virus 8 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection,09-06-2025
10068-5,S' wave amplitude in lead V5,09-06-2025
100685-7,JC virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection,09-06-2025
100686-5,JC virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection,09-06-2025
100687-3,JC virus DNA [Log #/volume] (viral load) in Urine by NAA with probe detection,09-06-2025
100688-1,Parvovirus B19 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection,09-06-2025
100689-9,Toxoplasma gondii DNA [Log #/volume] in Serum or Plasma by NAA with probe detection,09-06-2025
100690-7,Toxoplasma gondii DNA [Log #/volume] in Cerebral spinal fluid by NAA with probe detection,09-06-2025
100691-5,Varicella zoster virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection,09-06-2025
100692-3,Varicella zoster virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection,09-06-2025
10069-3,S' wave amplitude in lead V6,09-06-2025
100693-1,Pneumocystis jirovecii DNA [Log #/volume] in Respiratory system specimen by NAA with probe detection,09-06-2025
100694-9,SMN1 gene silent carrier analysis [Presence] in Blood or Tissue by Molecular genetics method,09-06-2025
100695-6,Genetic disease analysis overall carrier interpretation in Blood or Tissue by Molecular genetics method Narrative,09-06-2025
100696-4,CTNS related multigene analysis [Identifier] in Bodyfluid and Serum or Plasma by Molecular genetics method Nominal,09-06-2025
100697-2,Interventional radiology Outpatient Note,09-06-2025
100698-0,Social Determinants of Health screening report Document,09-06-2025
100699-8,Rifabutin+Ethambutol [Susceptibility],09-06-2025
100700-4,Trichomonas vaginalis DNA [Presence] in Urethra by NAA with probe detection,09-06-2025
10070-1,S' wave duration in lead AVF,09-06-2025
100701-2,Trichomonas vaginalis rRNA [Presence] in Urethra by NAA with probe detection,09-06-2025
100702-0,Mycoplasma genitalium rRNA [Presence] in Urethra by NAA with probe detection,09-06-2025
100703-8,Mycoplasma genitalium rRNA [Presence] in Urine by NAA with probe detection,09-06-2025
100704-6,Mycoplasma genitalium rRNA [Presence] in Cervix by NAA with probe detection,09-06-2025
100705-3,Mycoplasma genitalium rRNA [Presence] in Anorectal by NAA with probe detection,09-06-2025
100706-1,Mycoplasma genitalium rRNA [Presence] in Specimen by NAA with probe detection,09-06-2025
100707-9,Granulocytes [#/volume] in Peritoneal dialysis fluid by Automated count,09-06-2025
100708-7,Plasma cells/Leukocytes in Synovial fluid,09-06-2025
100709-5,Hepatocellular carcinoma risk [Score] by GAAD,09-06-2025
100710-3,Chlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Throat by NAA with probe detection,09-06-2025
100711-1,Borrelia burgdorferi.VlsE1+pepC10 Ab [Units/volume] in Serum by Immunoassay,09-06-2025
100712-9,Brexpiprazole [Mass/volume] in Serum or Plasma,09-06-2025
100713-7,Cariprazine [Mass/volume] in Serum or Plasma,09-06-2025
100714-5,Guanfacine [Mass/volume] in Serum or Plasma,09-06-2025
100715-2,Prothipendyl [Mass/volume] in Serum or Plasma,09-06-2025
100716-0,Prostate specific Ag [Mass/volume] in DBS,09-06-2025
100717-8,FCGR3A gene.p.Phe176Val [Presence] in Blood or Tissue by Molecular genetics method,09-06-2025
100718-6,Undersea and hyperbaric medicine Discharge summary,09-06-2025
10071-9,S' wave duration in lead AVL,09-06-2025
100719-4,Surgical oncology Discharge summary,09-06-2025
100720-2,Reproductive endocrinology and infertility Discharge summary,09-06-2025
100721-0,Community health care Discharge summary,09-06-2025
100722-8,Integrative medicine Discharge summary,09-06-2025
100723-6,Sports medicine Discharge summary,09-06-2025
100724-4,Diabetology Discharge summary,09-06-2025
100725-1,Optometry Discharge summary,09-06-2025
100726-9,Podiatry Discharge summary,09-06-2025
10072-7,S' wave duration in lead AVR,09-06-2025
100727-7,Chiropractic medicine Discharge summary,09-06-2025
100728-5,Cardiac surgery Discharge summary,09-06-2025
100729-3,Breastfeeding Discharge summary,09-06-2025
100730-1,Transplant surgery Discharge summary,09-06-2025
100731-9,Urgent care center Discharge summary,09-06-2025
100732-7,Cholesterol.in lipoprotein (little a) and Cholesterol.in LDL panel - Serum,09-06-2025
100733-5,Cholesterol in LDL [Mass/volume] in Serum by calculation --corrected for Cholesterol.in lipoprotein (little a),09-06-2025
100734-3,traMADol and Metabolites Panel - Urine by Confirmatory method,09-06-2025
10073-5,S' wave duration in lead I,09-06-2025
100735-0,Mannose-6-phosphate isomerase and phosphomannomutase 1 panel - Leukocytes,09-06-2025
100736-8,Acylcarnitine Analysis Post Mortem in Specimen Document,09-06-2025
100737-6,Alkaline phosphatase.macromolecular [Presence] in Serum or Plasma,09-06-2025
100738-4,Alanine aminotransferase.macromolecular [Presence] in Serum or Plasma,09-06-2025
100739-2,Aspartate aminotransferase.macromolecular [Presence] in Serum or Plasma,09-06-2025
1007-4,Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells,09-06-2025
100740-0,Amylase.macromolecular [Presence] in Serum or Plasma,09-06-2025
100741-8,Gamma glutamyl transferase.macromolecular [Presence] in Serum or Plasma,09-06-2025
100742-6,Lactate dehydrogenase.macromolecular [Presence] in Serum or Plasma,09-06-2025
10074-3,S' wave duration in lead II,09-06-2025
100743-4,Lipase.macromolecular [Presence] in Serum or Plasma,09-06-2025
100744-2,Alpha-1-acid glycoprotein [Mass/volume] in Serum or Plasma by Electrophoresis,09-06-2025
100745-9,Chloride [Moles/volume] in Mixed venous blood,09-06-2025
100746-7,Glucose [Moles/volume] in Mixed venous blood,09-06-2025
100747-5,Legionella serogroup panel - Specimen,09-06-2025
100748-3,Legionella spp [Presence] in Specimen by NAA with probe detection,09-06-2025
100749-1,Legionella pneumophila serogroup 1 [Presence] in Specimen by NAA with probe detection,09-06-2025
10075-0,S' wave duration in lead III,09-06-2025
100750-9,Legionella pneumophila non-serogroup 1 [Presence] in Specimen by NAA with probe detection,09-06-2025
100751-7,"Galactose-alpha-1,3-galactose (Alpha-Gal) panel - Serum or Plasma",09-06-2025
100752-5,Exacerbating factors - Reported,09-06-2025
100753-3,Alleviating factors - Reported,09-06-2025
100754-1,Platelet disorders multigene analysis in Blood or Tissue by Sequencing,09-06-2025
100755-8,Oligoclonal bands [#] in Serum or Plasma by Isoelectric focusing,09-06-2025
100756-6,Oligoclonal bands [Interpretation] in Cerebral spinal fluid by Isoelectric focusing,09-06-2025
100757-4,Protein fractions.oligoclonal bands panel - Serum and CSF by Isoelectric focusing,09-06-2025
100758-2,Estimated lung age by based on clinical data,09-06-2025
100759-0,Inspiratory reserve [Volume] Respiratory system by Spirometry,09-06-2025
100760-8,XR Radius and Ulna - left Single view,09-06-2025
100761-6,PALB2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method,09-06-2025
100762-4,HBA2 gene.c.377T>C [Presence] in Blood by Molecular genetics method,09-06-2025
100763-2,Mycobacterium sp comparative reaction interpretation Narrative,09-06-2025
100764-0,Mycobacterium bovis reaction wheal [Diameter] Qualitative --3 days post dose mammalian tuberculin intradermal,09-06-2025
100765-7,Homocysteine and methylmalonate and methylcitrate panel - DBS,09-06-2025
100766-5,Center for Epidemiologic Studies Depression Scale panel [CES-D],09-06-2025
100767-3,Bothered by things that are not usually bothersome,09-06-2025
10076-8,S' wave duration in lead V1,09-06-2025
100768-1,Poor appetite,09-06-2025
100769-9,Unhappy even with help from my family or friends,09-06-2025
100770-7,Feeling just as good as others,09-06-2025
100771-5,Trouble focusing,09-06-2025
100772-3,Feeling depressed,09-06-2025
100773-1,Feeling everything is too much of an effort,09-06-2025
100774-9,Feeling hopeful about the future,09-06-2025
100775-6,Feeling life had been a failure,09-06-2025
10077-6,S' wave duration in lead V2,09-06-2025
100776-4,Feeling fearful,09-06-2025
100777-2,Restless sleep,09-06-2025
100778-0,Feeling happy,09-06-2025
100779-8,Quieter than usual,09-06-2025
100780-6,Feeling lonely,09-06-2025
100781-4,People were unfriendly,09-06-2025
100782-2,Enjoying life,09-06-2025
100783-0,Crying spells,09-06-2025
10078-4,S' wave duration in lead V3,09-06-2025
100784-8,Feeling sad,09-06-2025
100785-5,Feeling people dislike me,09-06-2025
100786-3,Lack of energy,09-06-2025
100787-1,Total Score CES-D,09-06-2025
100788-9,Stemphylium botryosum IgG4 Ab [Mass/volume] in Serum,09-06-2025
100789-7,Rhizopus nigricans IgG4 Ab [Mass/volume] in Serum,09-06-2025
100790-5,Lepidoglyphus destructor IgG Ab [Mass/volume] in Serum,09-06-2025
100791-3,Hamster epithelium IgG Ab [Mass/volume] in Serum,09-06-2025
10079-2,S' wave duration in lead V4,09-06-2025
100792-1,Forsythia IgE Ab [Units/volume] in Serum,09-06-2025
100793-9,Testosterone [Mass/volume] in Body fluid,09-06-2025
100794-7,Follitropin [Units/volume] in Body fluid,09-06-2025
100795-4,S100 calcium binding protein B [Mass/volume] in Body fluid,09-06-2025
100796-2,Thyroglobulin [Mass/volume] in Body fluid,09-06-2025
100797-0,Testosterone Free [Mass/volume] in Serum --1st specimen post XXX challenge,09-06-2025
100798-8,Testosterone Free [Mass/volume] in Serum --2nd specimen post XXX challenge,09-06-2025
100799-6,21-Deoxycortisol [Mass/volume] in Serum --1st specimen post XXX challenge,09-06-2025
100-8,Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC),09-06-2025
10080-0,S' wave duration in lead V5,09-06-2025
100800-2,21-Deoxycortisol [Mass/volume] in Serum --2nd specimen post XXX challenge,09-06-2025
100801-0,21-Deoxycortisol [Mass/volume] in Serum --3rd specimen post XXX challenge,09-06-2025
100802-8,21-Deoxycortisol [Mass/volume] in Serum --4th specimen post XXX challenge,09-06-2025
100803-6,21-Deoxycortisol [Mass/volume] in Serum --5th specimen post XXX challenge,09-06-2025
100804-4,Vasopressin [Moles/volume] in Plasma --1st specimen post XXX challenge,09-06-2025
100805-1,Vasopressin [Moles/volume] in Plasma --2nd specimen post XXX challenge,09-06-2025
100806-9,Vasopressin [Moles/volume] in Plasma --3rd specimen post XXX challenge,09-06-2025
100807-7,Vasopressin [Moles/volume] in Plasma --4th specimen post XXX challenge,09-06-2025
100808-5,Vasopressin [Moles/volume] in Plasma --5th specimen post XXX challenge,09-06-2025
100809-3,Vasopressin [Moles/volume] in Plasma --6th specimen post XXX challenge,09-06-2025
100810-1,Vasopressin [Moles/volume] in Plasma --7th specimen post XXX challenge,09-06-2025
100811-9,Vasopressin [Moles/volume] in Plasma --8th specimen post XXX challenge,09-06-2025
100812-7,Vasopressin [Moles/volume] in Plasma --9th specimen post XXX challenge,09-06-2025
100813-5,Vasopressin [Moles/volume] in Plasma --10th specimen post XXX challenge,09-06-2025
100814-3,Vasopressin [Moles/volume] in Plasma --11th specimen post XXX challenge,09-06-2025
100815-0,Vasopressin [Moles/volume] in Plasma --12th specimen post XXX challenge,09-06-2025
100816-8,Glucagon [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge,09-06-2025
100817-6,Glucagon [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge,09-06-2025
10081-8,S' wave duration in lead V6,09-06-2025
100818-4,Renin [Mass/volume] in Plasma --1st specimen post XXX challenge,09-06-2025
100819-2,Renin [Mass/volume] in Plasma --2nd specimen post XXX challenge,09-06-2025
1008-2,Indirect antiglobulin test.polyspecific reagent [Presence] in Serum or Plasma,09-06-2025
100820-0,Renin [Mass/volume] in Plasma --3rd specimen post XXX challenge,09-06-2025
100821-8,National POLST form: portable medical order panel,09-06-2025
100822-6,Cardiopulmonary resuscitation orders,09-06-2025
100823-4,Initial portable medical treatment orders,09-06-2025
100824-2,Additional portable medical orders or instructions,09-06-2025
100825-9,Medically assisted nutrition orders,09-06-2025
10082-6,ST initial amplitude 6 ms in lead AVF,09-06-2025
100826-7,Portable medical order AndOr advance directive review,09-06-2025
100827-5,Portable medical order discussion participants,09-06-2025
100828-3,Portable medical order administrative information,09-06-2025
100829-1,Renin [Mass/volume] in Plasma --4th specimen post XXX challenge,09-06-2025
100830-9,Alpha subunit free [Units/volume] in Serum or Plasma --1st specimen post XXX challenge,09-06-2025
100831-7,Alpha subunit free [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge,09-06-2025
100832-5,Alpha subunit free [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge,09-06-2025
100833-3,Alpha subunit free [Units/volume] in Serum or Plasma --4th specimen post XXX challenge,09-06-2025
10083-4,ST initial amplitude 6 ms in lead AVL,09-06-2025
100834-1,Alpha subunit free [Units/volume] in Serum or Plasma --5th specimen post XXX challenge,09-06-2025
100835-8,Alpha subunit free [Units/volume] in Serum or Plasma --6th specimen post XXX challenge,09-06-2025
100836-6,Alpha subunit free [Units/volume] in Serum or Plasma --7th specimen post XXX challenge,09-06-2025
100837-4,Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge,09-06-2025
100838-2,Testosterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge,09-06-2025
100839-0,Vitamin A/Retinol binding protein [Ratio] in Serum or Plasma,09-06-2025
100840-8,IgE [Units/volume] in Body fluid,09-06-2025
100841-6,Zinc finger protein of the cerebellum 4 Ab [Presence] in Cerebral spinal fluid by Line blot,09-06-2025
10084-2,ST initial amplitude 6 ms in lead AVR,09-06-2025
100842-4,Nonalcoholic steatohepatitis score in Serum or Plasma Calculated by FAST,09-06-2025
100843-2,Liver fibrosis score in Serum or Plasma by Calculated.Agile3+,09-06-2025
100844-0,Liver fibrosis score in Serum or Plasma by Calculated.Agile4,09-06-2025
100845-7,Neurofascin155 IgG4 Ab [Presence] in Serum by Flow cytometry (FC),09-06-2025
100846-5,Dengue virus 1+2+3+4 nsP1 IgG Ab [Presence] in Serum or Plasma by Immunoassay,09-06-2025
100847-3,Gas and ammonia panel - Arterial blood,09-06-2025
100848-1,Cell count and Differential panel - Amniotic fluid by Manual count,09-06-2025
100849-9,Leukocytes [#/volume] in Amniotic fluid by Manual count,09-06-2025
100850-7,Neutrophils [#/volume] in Amniotic fluid by Manual count,09-06-2025
100851-5,Other cells [#/volume] in Amniotic fluid by Manual count,09-06-2025
100852-3,NM Bones Views for metastasis W Sr-89 IV,09-06-2025
100853-1,NM Pericardial space Views for effusion,09-06-2025
100854-9,Lymphocytes/cells in Blood mononuclear cells by Immunoassay,09-06-2025
100855-6,CD3 cells/cells in Blood mononuclear cells,09-06-2025
100856-4,CD3+CD4+ (T4 helper) cells/cells in Blood mononuclear cells,09-06-2025
100857-2,CD3+CD8+ (T8 suppressor) cells/cells in Blood mononuclear cells,09-06-2025
100858-0,Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide,09-06-2025
10085-9,ST initial amplitude 6 ms in lead I,09-06-2025
100859-8,Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide,09-06-2025
100860-6,Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide,09-06-2025
100861-4,Cells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide,09-06-2025
100862-2,Cells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide,09-06-2025
100863-0,Cells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide,09-06-2025
100864-8,Giardia lamblia bg gene [Genotype] in Specimen by Molecular genetics method,09-06-2025
100865-5,Avian schistosomes DNA [Presence] in Specimen by NAA with probe detection,09-06-2025
100866-3,Febrile antibody profile in Serum,09-06-2025
10086-7,ST initial amplitude 6 ms in lead II,09-06-2025
100867-1,Campylobacter jejuni+coli+lari+upsaliensis Ag [Presence] in Stool by Rapid immunoassay,09-06-2025
100868-9,Cryptosporidium sp 18S-LC2 rRNA [Genotype] in Specimen by Molecular genetics method,09-06-2025
100869-7,Cryptosporidium gp60 gene [Type] in Specimen by Molecular genetics method,09-06-2025
100870-5,Cryptosporidium 18S rRNA [Genotype] in Specimen by Molecular genetics method,09-06-2025
100871-3,Giardia lamblia gdh gene [Genotype] in Specimen by Molecular genetics method,09-06-2025
100872-1,Bacteria producing polysaccharide from sucrose [Presence] in Isolate,09-06-2025
100873-9,Giardia lamblia tpi gene [Genotype] in Specimen by Molecular genetics method,09-06-2025
100874-7,Basidiobolus sp [Presence] in Specimen,09-06-2025
10087-5,ST initial amplitude 6 ms in lead III,09-06-2025
100875-4,Fetal Heart Document limited US,09-06-2025
100876-2,Fetal Heart Document US,09-06-2025
100877-0,US Heart Transesophageal during surgery,09-06-2025
100878-8,Endoscopic ultrasound study Upper GI tract Document,09-06-2025
100879-6,US Guidance for cryoablation of Breast - right,09-06-2025
100880-4,US Guidance for cryoablation of Breast - left,09-06-2025
100881-2,MR Guidance for cryoablation of Bone,09-06-2025
100882-0,MR Peritoneum W contrast percutaneous intraperitoneal,09-06-2025
10088-3,ST initial amplitude 6 ms in lead V1,09-06-2025
100883-8,MR Guidance for biopsy of Kidney - left,09-06-2025
100884-6,MR Guidance for biopsy of Kidney - right,09-06-2025
100885-3,Parapoxvirus DNA [Presence] in Specimen by NAA with probe detection,09-06-2025
100886-1,Orf virus DNA [Presence] in Specimen by NAA with probe detection,09-06-2025
100887-9,Pseudocowpox virus DNA [Presence] in Specimen by NAA with probe detection,09-06-2025
100888-7,Monkeypox virus clade II DNA [Presence] in Specimen by NAA with probe detection,09-06-2025
100889-5,Monkeypox virus clade I DNA [Presence] in Specimen by NAA with probe detection,09-06-2025
100890-3,Poxvirus DNA panel,09-06-2025
10089-1,ST initial amplitude 6 ms in lead V2,09-06-2025
100891-1,Orthopoxvirus IgG Ab [Presence] in Serum or Plasma by Immunoassay,09-06-2025
100892-9,Orthopoxvirus IgM Ab [Presence] in Serum or Plasma by Immunoassay,09-06-2025
100893-7,Orthopoxvirus IgG and IgM Ab panel - Serum or Plasma,09-06-2025
100894-5,Recommended screening frequency Narrative,09-06-2025
100895-2,Rickettsia conorii IgG and IgM [Interpretation] in Serum,09-06-2025
100896-0,Vasopressin [Moles/volume] in Plasma --13th specimen post XXX challenge,09-06-2025
100897-8,Staphylococcus aureus [Presence] in Specimen by Organism specific culture,09-06-2025
100898-6,Lipid panel - Serum or Plasma,09-06-2025
100899-4,Enterobacteriaceae.extended spectrum beta lactamase resistance phenotype [Identifier] in Specimen by Organism specific culture,09-06-2025
